Dr. Tsai is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
910 E 26th St
Suite 100-200
Minneapolis, MN 55404Phone(612) 884-6300
Fax(612) 884-6363- Is this information wrong?
Education & Training
Harvard Medical SchoolClass of 1998- Duke UniversityBS, Chemistry and Religion, Summa Cum Laude, 1990 - 1994
Certifications & Licensure
MN State Medical License 2000 - 2021- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of LY2835219 Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer Start of enrollment: 2014 Jul 01Panwalkar, A.,Tiersten, A.,WHITTENBERGER, B.,Stokoe, C.,Jones, C.,Patt, D.,Tamkus, D.,Khan, D.,Khan, F.,Holmes, F.,Wright, G.,Sledge, G.,Wang, G.,Koh, H.,Soliman, H.,Rugo, H.,Reynolds, J.,Vu, J.,Beck, J.,...
- A Randomized Double-blind, Placebo-controlled Study of LEE011 in Combination With Letrozole for the Treatment of Postmenopausal Women With Hormone Receptor Positive, HER2 Negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease Start of enrollment: 2013 Dec 01Novartis Pharmaceuticals
- A Phase 3, Open-Label, Randomized, Parallel, 2-Arm, Multi-Center Study of BMN 673 Versus Physician's Choice in Germline BRCA Mutation Subjects With Locally Advanced and/or Metastatic Breast Cancer, Who Have Received No More Than 2 Prior Chemotherapy Regim Start of enrollment: 2013 Oct 01Seneviratne, L.C.,Mahtani, R.L.,Kakarala, M.,McIntyre, K.J.,Hurvitz, S.A.,Byeff, P.D.,Henry, N.L.,Blum, J.L.,Eisenberg, P.D.,Diab, S.,Mina, L.A.,Yardley, D.A.,Danso, M.A.,Lindquist, D.L.,Fehrenbacher, L.,...
- Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 01Pisani, A.L.,Burnett, A.F.,Guirguis, A.S.,Brockmeyer, A.D.,Green, A.E.,Kueck, A.S.,Kamat, A.A.,Edraki, B.,Marchello, B.T.,Rimel, B.J.,Johnston, C.M.,Holschneider, C.H.,Cathcart, C.K.,Chase, D.M.,Alberts, ...
- PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score Start of enrollment: 2012 May 01Dooley, W.C.,Whitworth, P.W.,Oldham, D.S.,Riseberg, D.A.,Soliman, H.,Berkowitz, M.J.,Favis, G.,Srinivasiah, J.,Mroz, C.T.,Gunn, S.,Gorbaty, M.,Tsai, M.,Komenaka, I.K.,Durkin, W.J.,Shah, S.N.,Barginear, M....
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 01Dubey, A.K.,Pisani, A.L.,Mahdavi, A.,Brockmeyer, A.D.,Green, A.E.,Yetter, A.W.,Secord, A.A.,Kamat, A.A.,Greer, B.E.,Marchello, B.T.,Kim, B.,Cracchiolo, B.M.,Sleckman, B.G.,Knab, B.R.,Service, C.I.,Miller,...
Publications & Presentations
PubMed
- Effects of Germline Pathogenic Variants, Cancer Subtypes, Tumor-related Characteristics, and Pregnancy-associated Diagnosis on Outcomes.Michaela L. Tsai, Monica Knaack, Parker Martone, Janet Krueger, Shari Baldinger, Tamera J. Lillemoe, Barbara Susnik, Erin Grimm, Susan Olet, Natasha Rueth, Karen K. Sw...> ;Clinical Breast Cancer. 2021 Feb 1
- 2 citationsEfficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 Study.Denise A. Yardley, Lowell L. Hart, Anne Favret, Sibel Blau, Sami Diab, Donald A. Richards, Joseph A. Sparano, J. Thad Beck, Paul Richards, Patrick J. Ward, Bhuvaneswar...> ;Clinical Breast Cancer. 2019 Feb 28
- Predictive value of breast magnetic resonance imaging in detecting mammographically occult contralateral breast cancer: Can we target women more likely to have contral...Susnik, B.,Schneider, L.,Swenson, K. K.,Krueger, J.,Braatz, C.,Lillemoe, T.,Tsai, M.,DeFor, T. E.,Knaack, M.,Rueth, N.> ;J Surg Oncol. 2018 Sep 10
- Join now to see all
Journal Articles
- Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral LetterAlyssa Kne, Heather Zierhut, Michaela L Tsai, Journal of Genetic Counseling
Press Mentions
70-Gene Signature Impacts Treatment Decisions in Breast CAOctober 29th, 2017
New Data Shows Agendia’s MammaPrint® Can Prevent Under and over Treatment of Breast Cancer Patients with an Intermediate/Indeterminate OncotypeDx Recurrence ScoreJune 7th, 2016- Agendia Appoints Dr. Gabriel Hortobagyi as Chairman to Their Medical Advisory BoardJune 1st, 2016
Hospital Affiliations
Abbott Northwestern HospitalMinneapolis, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
